Stay updated on Novel Therapeutics for High-Risk AML Clinical Trial
Sign up to get notified when there's something new on the Novel Therapeutics for High-Risk AML Clinical Trial page.

Latest updates to the Novel Therapeutics for High-Risk AML Clinical Trial page
- CheckyesterdayChange DetectedThe record history page reflects routine updates to the displayed version list and site/view revision information (moving from one revision/version label to the next). It also includes new/removed entries around recent submission dates for contacts and study status in the history log.SummaryDifference0.2%

- Check8 days agoChange DetectedAdded Contacts/Locations and Study Status sections. Revision updated from v3.5.0 to v3.5.2.SummaryDifference0.2%

- Check15 days agoChange DetectedNew version history entries 223–226 were added, including updates to Study Status and Contacts/Locations.SummaryDifference0.3%

- Check22 days agoChange DetectedNew entries for Study Status and Contacts/Locations were added to the record history, showing updated status and location/contact details.SummaryDifference0.4%

- Check29 days agoChange DetectedThe study record shows additions and updates to Study Status and Contacts/Locations for recent dates (2026-03-20 to 2026-03-27), reflecting current status and site details.SummaryDifference0.4%

- Check37 days agoChange DetectedThe history adds new version entries (211, 210, 209) with updates to Study Status and Contacts/Locations, and introduces Revision: v3.5.0 (replacing v3.4.3).SummaryDifference0.4%

Stay in the know with updates to Novel Therapeutics for High-Risk AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Novel Therapeutics for High-Risk AML Clinical Trial page.